Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 810 results for "daiichi sankyo"

Competition Commission extends Sun Pharma-Ranbaxy probe to new stage
Livemint.com

Competition Commission extends Sun Pharma-Ranbaxy probe to new...

Sun Pharma agreed to buy Ranbaxy for $3.2 billion in stock from its Japanese parent Daiichi Sankyo in a deal that would create the world's fifth largest generic drugmaker. Photo: Bloomberg New Delhi: India's antitrust regulator has ordered a ... Livemint.com, 2 days ago

16 images for daiichi sankyo

Pharma Letter, 1 week ago
I Stock Analyst, 3 weeks ago
Drug Discovery and Development, 2 days ago
Bio Spectrum Asia, 2 days ago
Pharma Letter, 3 weeks ago
Drug Discovery and Development, 1 week ago
Pharma Letter, 1 week ago
Drug Discovery and Development, 3 weeks ago
Pharma Letter, 3 weeks ago
4 Traders, 1 month ago
Pharma Letter

Daiichi Sankyo links with Kaketsuken for Bimmugen sales

Japanese drug major Daiichi Sankyo (TYO: 4568) has signed a cooperative sales agreement with The Chemo-Sero-Therapeutic Research Institute (Kaketsuken) for its recombinant adsorbed hepatitis B vaccine (yeast-derived), Bimmugen. Kaketsuken ...
 Pharma Letter2 days ago DAIICHI SANKYO : Announces Cooperative Sales Agreement for the Recombinant Adsorbed Hepatitis B Vaccine Bimmugen®  4 Traders3 days ago DAIICHI SANKYO : Study Results from Daiichi Sankyo Broaden Understanding of Pituitary Hormone Release Inhibiting Hormones (Impaired excitability of somatostatin- and...  4 Traders3 days ago Daiichi Sankyo announces cooperative sales agreement for the recombinant adsorbed hepatitis B vaccine Bimmugen®  European Pharmaceutical Review2 days ago
[x]  

Sun Pharmaceutical banks on Daiichi Sankyo to crack Japan market

NEW DELHI: , which is in the process of acquiring control of Ranbaxy Laboratories from Daiichi Sankyo, will soon put its purchase to work through the exclusive marketing opportunity offered by two drugs in the US, rationalising research and other ...
 Economic Times2 weeks ago Sun Pharma banks on Daiichi Sankyo to enter Japan market: Reports  India Infoline2 weeks ago INDIA PRESS-Sun Pharma banks on Daiichi Sankyo to crack Japan market-Economic Times  Reuters UK2 weeks ago
[x]  

DAIICHI SANKYO : Reports on Medicinal Chemistry from Daiichi Sankyo Provide New Insights [Synthesis and SAR studies of benzyl ether derivatives as potent orally...

Reports on Medicinal Chemistry from Daiichi Sankyo Provide New Insights [Synthesis and SAR studies of benzyl ether derivatives as potent orally active S1P(1) agonists] By a News Reporter-Staff News Editor at Health & Medicine Week -- Fresh data ...
 4 Traders3 days ago Daiichi-Sankyo reports higher Q1 profit, provides annual outlook  Individual.com1 week ago

Daiichi Sankyo, Biota's laninamivir fails to meet goal of mid-stage influenza trial

Biota Pharmaceuticals announced Friday that a Phase II study of laninamivir octanoate failed to meet its primary endpoint of significantly reducing the median time to alleviation of influenza symptoms versus placebo. The IGLOO trial included 639 ...
 FirstWord Pharma4 weeks ago Rigel Pharma Dry Eye Drug Fails Phase 2 Testing; Shares Plummet  Bidness Etc2 weeks ago Rigel Pharmaceuticals, Inc. Experimental Eye Drug R348 Fails Mid-Stage Study  BioSpace2 weeks ago R348 Did Not Meet Endpoints in Phase 2 Dry Eye Study  Industrial Info Financials2 weeks ago
[x]  

Sun Pharma likely to enter Japanese market in four years

Sun Pharmaceuticals is reportedly planning to enter the Japanese market riding on its association with Daiichi Sankyo from which it is buying Ranbaxy Laboratories. The Economic Times has reported that the drug company is likely to introduce its ...
 Pharmaceutical Business Review2 weeks ago Bharat Book Bureau: Global Pharmaceutical and Biotechnology Outlook 2014 - Japan Pharma  Pharmacy Choice2 weeks ago SUN PLANS TO RISE IN JAPAN'S PHARMA MARKET  Pharmacy Choice2 weeks ago

Daiichi Sankyo: Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2015

Downloa
 FirstWord Pharma4 weeks ago

An antidote for Factor Xa inhibitors

SOUTH SAN FRANCISCO, Calif.—Portola Pharmaceuticals has entered into a second clinical collaboration agreement with Daiichi Sankyo to study andexanet alfa, Portola's investigational Factor Xa inhibitor antidote, in Phase 3 registration studies ...
 Drug Discovery News2 weeks ago Rigel Announces Second Quarter 2014 Financial Results  Pettinga Financial Advisors3 weeks ago Portola Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update  Virtual Strategy Magazine3 weeks ago
Market Pulse Navigator

The International Bio-Communit ...

Drug discovery, regenerative medicine, personalized medicine, functional foods, bio-energy and imaging -- TOKYO. - Friday, August 29th 2014 [ME NewsWire] BioJapan 2014 World Business Forum (BUSINESS WIRE) BioJapan 2014 World Business ...
 World Connector Net2 hours ago Bio-comunidade internacional se encontra no Japão! Anunciando evento de negócios integrados de biotecnologia - BioJapan 2014  Business Wire2 days ago ¡La Biocomunidad Internacional Se Reúne en Japón! Se Anuncia el Evento Comercial de Biotecnología Integrado - BioJapan 2014  Business Wire2 days ago Die internationale Bio-Gemeinschaft trifft sich in Japan! Ankündigung des Integrated Biotech Business Event - BioJapan 2014  Business Wire2 days ago
[x]  

Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome: The SOLID-TIMI 52 Randomized Clinical Trial

Group Information: A list of the SOLID-TIMI 52 Investigators is included in Supplement 1 . Corresponding Author: Michelle L. ODonoghue, MD, MPH, TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, 350 Longwood Ave, First ...
 Journal of the American Medical Association2 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less